We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CUTR
401
DELISTED
Cutera, Inc.
CUTR
| $56K | ﹤0.01% |
+2,303
| New | +$49.2K |
|
|
CERN
402
DELISTED
Cerner Corp
CERN
| $56K | ﹤0.01% |
+708
| New | +$52.5K |
|
403
Broadridge
BR
$19.6B
| $55K | ﹤0.01% |
+359
| New | +$52.1K |
|
404
Cognizant
CTSH
$24.7B
| $55K | ﹤0.01% |
+671
| New | +$51.1K |
|
405
Gartner
IT
$12.3B
| $55K | ﹤0.01% |
+343
| New | +$49.4K |
|
406
MGM Resorts International
MGM
$11.6B
| $55K | ﹤0.01% |
+1,756
| New | +$45.2K |
|
407
Chefs' Warehouse
CHEF
$4.49B
| $54K | ﹤0.01% |
+2,119
| New | +$41.7K |
|
408
Marriott International
MAR
$89.8B
| $54K | ﹤0.01% |
+409
| New | +$46.7K |
|
409
Wynn Resorts
WYNN
$10.1B
| $54K | ﹤0.01% |
+479
| New | +$44.2K |
|
410
Advanced Micro Devices
AMD
$862B
| $53K | ﹤0.01% |
+579
| New | +$50K |
|
|
BELFB
411
Bel Fuse Inc Class B
BELFB
$4.23B
| $53K | ﹤0.01% |
+3,553
| New | +$47.8K |
|
412
CONMED
CNMD
$1.51B
| $53K | ﹤0.01% |
+476
| New | +$45.1K |
|
413
Host Hotels & Resorts
HST
$17.2B
| $53K | ﹤0.01% |
+3,609
| New | +$46.7K |
|
414
IBM
IBM
$219B
| $53K | ﹤0.01% |
+442
| New | +$51.1K |
|
415
Intel
INTC
$509B
| $53K | ﹤0.01% |
+1,065
| New | +$52K |
|
416
Knowles
KN
$3.43B
| $53K | ﹤0.01% |
+2,851
| New | +$47.7K |
|
417
Leidos
LDOS
$16.2B
| $53K | ﹤0.01% |
+502
| New | +$48.1K |
|
418
NVIDIA
NVDA
$5.13T
| $53K | ﹤0.01% |
+4,080
| New | +$54.6K |
|
419
Simulations Plus
SLP
$371M
| $53K | ﹤0.01% |
+743
| New | +$49.3K |
|
420
State Street
STT
$51.2B
| $53K | ﹤0.01% |
+731
| New | +$49.6K |
|
421
Welltower
WELL
$165B
| $53K | ﹤0.01% |
+826
| New | +$50.1K |
|
|
INFO
422
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $53K | ﹤0.01% |
+585
| New | +$50.7K |
|
423
Adtran
ADTN
$725M
| $52K | ﹤0.01% |
+3,521
| New | +$44.7K |
|
|
DCH
424
Dauch Corp
DCH
$1.41B
| $52K | ﹤0.01% |
+6,283
| New | +$47.3K |
|
425
Genuine Parts
GPC
$18.2B
| $52K | ﹤0.01% |
+517
| New | +$50.6K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.